{
    "nctId": "NCT03811509",
    "briefTitle": "Breast Cancer Women on Aromatase Inhibitors Treatment",
    "officialTitle": "Study for Improving Life Quality in Breast Cancer Women Treated With Aromatase Inhibitors: Cohort B-ABLE",
    "overallStatus": "UNKNOWN",
    "conditions": "Osteoporosis, Osteoporosis Fracture, Arthralgia Generalized",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "bone mass measured by dual energy x-ray absorptiometry (DEXA) densitometry",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women with early breast cancer estrogen receptor with aromatase inhibitors treatment\n\nExclusion Criteria:\n\n* Previous treatment with antiresorptive treatment for osteoporosis secondary osteoporosis, as corticosteroids, Hyperparathyroidism, Kidney Chronic disease, previous treatment with aromatase inhibitors Diabetes mellitus type 1 Fibromyalgia",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}